Tosin Yinka Akintunde1,2,3, Taha Hussein Musa3,4,5, Hassan Hussein Musa6, Shaojun Chen1, Elhakim Ibrahim7, Sayibu Muhideen8, Joseph Kawuki9. 1. Department of Sociology, School of Public Administration, Hohai University, Nanjing, China. 2. Department of Demography and Social Statistics, Obafemi Awolowo University, Nigeria. 3. Organization of African Academic Doctor (OAAD), Nairobi, Kenya. 4. Key Laboratory of Environmental Medicine Engineering, Ministry of Education; Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, China. 5. Biomedical Research Institute, Darfur University College, Nyala, Sudan. 6. Department of Medical Microbiology, Faculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan. 7. Department of Demography, College for Health, Community and Policy, The University of Texas at San Antonio, San Antonio, Texas, USA. 8. Department of Philosophy of Science and Technology, University of Science and Technology of China, Hefei, China. 9. Centre for Health Behaviours Research, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, China, Hong Kong.
Abstract
Introduction: The Ebola Virus outbreak in Africa is believed to be one of the deadliest viral infections that causes severe hemorrhagic fever in human and nonhuman primates, which has resulted in increased mortality rates in the affected African countries. Thus, the current study mapped and quantified global research output and trends in the EBOV vaccine publications via a bibliometric analysis. Methods: Publications about the Ebola virus vaccine were extracted from the Web of Science and Scopus databases. HistCite, Bibliometrix, an R package, and VOSviewer.Var1.6.6 were used for data mapping and analysis. Results: A total of 541 (WoS) and 511 (Scopus) documents were included, with a cumulation of 24,611 citations in both databases. These documents were published in 141 journals in the Wos and 185 in Scopus. The USA was the most productive country with 206 (38.08%) publications in the Wos. Although the top-cited authors are from the USA, the United Kingdom, and Canada, only one author from Africa "Samai M" from the University of Sierra Leone contributed 13 publications. Meanwhile, the Journal of Infectious Diseases was the most productive (45, 8.32%) in this field. Conclusion: The study provides insight for researchers and health policy on the trends and progress of the EBOV vaccine research and development, focusing on the hot topics, research collaboration, and research dearth that requires urgent redress to fast-track an all-inclusive EBOV vaccine development.
Introduction: The Ebola Virus outbreak in Africa is believed to be one of the deadliest viral infections that causes severe hemorrhagic fever in human and nonhuman primates, which has resulted in increased mortality rates in the affected African countries. Thus, the current study mapped and quantified global research output and trends in the EBOV vaccine publications via a bibliometric analysis. Methods: Publications about the Ebola virus vaccine were extracted from the Web of Science and Scopus databases. HistCite, Bibliometrix, an R package, and VOSviewer.Var1.6.6 were used for data mapping and analysis. Results: A total of 541 (WoS) and 511 (Scopus) documents were included, with a cumulation of 24,611 citations in both databases. These documents were published in 141 journals in the Wos and 185 in Scopus. The USA was the most productive country with 206 (38.08%) publications in the Wos. Although the top-cited authors are from the USA, the United Kingdom, and Canada, only one author from Africa "Samai M" from the University of Sierra Leone contributed 13 publications. Meanwhile, the Journal of Infectious Diseases was the most productive (45, 8.32%) in this field. Conclusion: The study provides insight for researchers and health policy on the trends and progress of the EBOV vaccine research and development, focusing on the hot topics, research collaboration, and research dearth that requires urgent redress to fast-track an all-inclusive EBOV vaccine development.
Entities:
Keywords:
Ebola virus; Ebola virus vaccine; VOSviewer; bibliometric; web of science
Authors: Ana Maria Henao-Restrepo; Anton Camacho; Ira M Longini; Conall H Watson; W John Edmunds; Matthias Egger; Miles W Carroll; Natalie E Dean; Ibrahima Diatta; Moussa Doumbia; Bertrand Draguez; Sophie Duraffour; Godwin Enwere; Rebecca Grais; Stephan Gunther; Pierre-Stéphane Gsell; Stefanie Hossmann; Sara Viksmoen Watle; Mandy Kader Kondé; Sakoba Kéïta; Souleymane Kone; Eewa Kuisma; Myron M Levine; Sema Mandal; Thomas Mauget; Gunnstein Norheim; Ximena Riveros; Aboubacar Soumah; Sven Trelle; Andrea S Vicari; John-Arne Røttingen; Marie-Paule Kieny Journal: Lancet Date: 2016-12-23 Impact factor: 79.321
Authors: Cordelia E M Coltart; Benjamin Lindsey; Isaac Ghinai; Anne M Johnson; David L Heymann Journal: Philos Trans R Soc Lond B Biol Sci Date: 2017-05-26 Impact factor: 6.237
Authors: Mohamad Chahrour; Sahar Assi; Michael Bejjani; Ali A Nasrallah; Hamza Salhab; Mohamad Fares; Hussein H Khachfe Journal: Cureus Date: 2020-03-21
Authors: Ibrahim H Musa; Lukman O Afolabi; Ibrahim Zamit; Taha H Musa; Hassan H Musa; Andrew Tassang; Tosin Y Akintunde; Wei Li Journal: Cancer Control Date: 2022 Jan-Dec Impact factor: 2.339